Avenge Bio
Closed- Website
- avengebio.com
- Total Funding
- $45.0M
- Last Round
- $45.0M Series AJan 2022
- Rounds
- 1
About
Biotechnology company developing the LOCOcyte cell-therapy platform for immunotherapeutics dosing
Summary
It has raised $45.0M in total across 1 round, most recently a $45.0M Series A round in Jan 2022. Investors include Perceptive Advisors and CAM Capital.
Funding History
$45.0M
Jan 2022
Investors
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/avenge-bio"><img src="https://indexed.vc/api/badge/company/avenge-bio" alt="Avenge Bio on Indexed.vc" width="260" height="76" /></a>